Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global Point-of-Care Molecular Diagnostics Market is Expected to Expand at a Healthy Growth Rate of ~10% by 2034 | DelveInsight

globenewswire.com
BDX Listed as a key player in point-of-care diagnostics, molecular diagnostics, in-vitro diagnostics, and polymerase chain reaction markets, showing broad engagement in the sector. DHR Identified as a key player in point-of-care diagnostics and molecular diagnostics, and its subsidiary Beckman Coulter is mentioned in in-vitro diagnostics, indicating significant presence. ABT Mentioned as a key player in point-of-care diagnostics, molecular diagnostics, in-vitro diagnostics, and polymerase chain reaction markets, highlighting its broad involvement. QDEL Identified as a key player in the point-of-care molecular diagnostics market, indicating its role in this specific sector. FLUX Listed as a key player in the point-of-care molecular diagnostics market, indicating its involvement in this specific area. TMO Mentioned as a key player in point-of-care diagnostics, molecular diagnostics, in-vitro diagnostics, next-generation sequencing, and polymerase chain reaction markets, showing broad engagement. DGX Identified as a key player in the point-of-care molecular diagnostics market, indicating its role in this specific sector. ILMN Identified as a key player in molecular diagnostics and next-generation sequencing markets, indicating its role in these sectors. EXAS Listed as a key player in the molecular diagnostics market, indicating its involvement in this specific area. BIO Mentioned as a key player in in-vitro diagnostics, next-generation sequencing, and polymerase chain reaction markets, showing its presence in these areas. BIIB Although not directly mentioned, the context of diagnostics and molecular testing in healthcare could imply relevance for companies in the biotech sector. GILD Although not directly mentioned, the context of diagnostics and molecular testing in healthcare could imply relevance for companies in the biotech sector. AMGN Although not directly mentioned, the context of diagnostics and molecular testing in healthcare could imply relevance for companies in the biotech sector. MRK Mentioned as a key player in the polymerase chain reaction market, indicating its role in this specific sector. PACB Listed as a key player in the next-generation sequencing market, indicating its involvement in this specific area. CRSP Although not directly mentioned, the article's focus on molecular diagnostics and genetic markers could be relevant to CRISPR technology. EDIT Although not directly mentioned, the article's focus on molecular diagnostics and genetic markers could be relevant to gene editing technologies. BEAM Although not directly mentioned, the article's focus on molecular diagnostics and genetic markers could be relevant to base editing technologies.

Global Point-of-Care Molecular Diagnostics Market is Expected to Expand at a Healthy Growth Rate of ~10% by 2034 | DelveInsight New York, USA, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Global Point-of-Care Molecular Diagnostics Market is Expected to Expand at a Healthy Growth Rate of ~10% by 2034 | DelveInsight

The point-of-care molecular diagnostics Market is experiencing robust growth, driven by the increasing demand for rapid, accurate, and decentralized diagnostic testing across infectious diseases, oncology, and chronic disease management. Advances in portable molecular platforms, automated sample-to-answer technologies, and multiplex testing capabilities are improving diagnostic efficiency in hospitals, clinics, and remote healthcare settings. Growing adoption of point-of-care testing, expanding healthcare access in emerging markets, and continued investments in molecular diagnostic innovation are further supporting market expansion. Additionally, favorable regulatory support and the rising emphasis on early disease detection and personalized treatment are expected to sustain strong market growth over the coming years.

DelveInsight’s Point-of-Care Molecular Diagnostics Market Insights report provides the current and forecast market analysis, individual leading point-of-care molecular diagnostics companies’ market shares, challenges, point-of-care molecular diagnostics market drivers, barriers, trends, and key point-of-care molecular diagnostics companies in the market.

Point-of-Care Molecular Diagnostics Market Summary

To read more about the latest highlights related to the point-of-care molecular diagnostics market, get a snapshot of the key highlights @ https://www.delveinsight.com/report-store/point-of-care-molecular-diagnostics-market

Key Factors Contributing to the Rise in Growth of the Point-of-Care Molecular Diagnostics Market

Get a sneak peek at the point-of-care molecular diagnostics market dynamics @ Point-of-Care Molecular Diagnostics Market Trends

Regional Point-of-Care Molecular Diagnostics Market Insights

North America

Europe

Asia-Pacific

To know more about why North America is leading the market growth in the point-of-care molecular diagnostics market, get a snapshot of the Point-of-Care Molecular Diagnostics Market Share

Recent Developmental Activities in the Point-of-Care Molecular Diagnostics Market

What is Point-of-Care Molecular Diagnostics?

Point-of-care molecular diagnostics refers to rapid, nucleic acid-based testing performed at or near the site of patient care, such as hospitals, clinics, emergency departments, physician offices, pharmacies, or even at home. Unlike conventional laboratory testing, which often requires specialized equipment and longer turnaround times, POC molecular diagnostics integrates advanced technologies such as polymerase chain reaction (PCR), isothermal amplification, and CRISPR-based detection into compact, user-friendly platforms that deliver accurate results within minutes to an hour. These tests enable the direct detection of pathogens or disease-specific genetic markers, facilitating early diagnosis, timely treatment decisions, and improved patient management. The growing demand for decentralized healthcare, rapid infectious disease detection, personalized medicine, and real-time clinical decision-making has positioned point-of-care molecular diagnostics as a critical component of modern healthcare systems, particularly in managing infectious diseases, oncology, and genetic disorders.

Point-of-Care Molecular Diagnostics Market Assessment

Which MedTech key players in the point-of-care molecular diagnostics market are set to emerge as the trendsetter explore @ Point-of-Care Molecular Diagnostics Market Analysis

Table of Contents

Interested in knowing the point-of-care molecular diagnostics market share by 2034? Click to get a snapshot of the Point-of-Care Molecular Diagnostics Market Size

Related Reports

Point-of-Care Diagnostics Market

Point-of-Care Diagnostics Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key point-of-care diagnostics companies such as F. Hoffmann-La Roche Ltd., BD, Danaher, Abbott, Siemens Healthcare Private Limited, Nova Biomedical, Quidel Corporation, Chembio Diagnostics, Inc., EKF Diagnostics Holdings plc., Trinity Biotech, Fluxergy, Thermo Fisher Scientific, Quest Diagnostics Incorporated, DiaSys Diagnostics India Pvt Ltd., Cipla, Sysmex Europe SE, Lumos Diagnostics™, Trivitron Healthcare, Getein Biotech, Inc., ACON Laboratories, Inc., and others.

Molecular Diagnostics Market

Molecular Diagnostics Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key molecular diagnostics companies, including Hoffmann-La Roche Ltd., Hologic, Inc., bioMérieux SA, Abbott, QIAGEN, BD, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Danaher, Myriad Genetics, Inc., Agilent Technologies Inc., Illumina Inc., DiaSorin Inc., MDxHealth, Genetic Signatures, Biocartis, Exact Sciences Corporation, Amoy Diagnostics Co. Ltd., Molbio Diagnostics Pvt. Ltd., Savyon Diagnostics, and others.

In-vitro Diagnostics Market

In-vitro Diagnostics Market Insights, Competitive Landscape, and Market Forecast – 2034 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key in-vitro diagnostics companies, including F. Hoffmann-La Roche Ltd, Abbott, FUJIFILM Corporation, Sysmex Corporation, Siemens Healthcare GmbH, BD, Seegene Inc, Beckman Coulter, Inc ( Danaher Corporation), QIAGEN, bioMérieux SA, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc, Cisbio (PerkinEemer), ARKRAY, Inc, Ortho Clinical Diagnostics, ACON Laboratories, Inc., Teco Diagnostics, EKF Diagnostics, Besurence GmbH, Savyon Diagnostics, HORIBA, Ltd., Palliance AB, Sugentech, Inc, Cypress Diagnostics, Salignostics, The Menarini Group, DxGen Corp, HUMAN, Nova Biomedical, Asahi Kasei Pharma Corporation, Agilent Technologies, Inc., and others.

Next-Generation Sequencing Market

Next-Generation Sequencing Market Insights, Competitive Landscape, and Market Forecast – 2034 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key NGS companies, including Agilent Technologies, Inc., Illumina Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, QIAGEN, Thermo Fisher Scientific, PerkinElmer Inc., MedGenome, BGI, Pacific Biosciences, GENEWIZ, Oxford Nanopore Technologies plc., Psomagen, Inc., 10x Genomics, Takara Bio Inc., Zymo Research Corporation, NuGEN Technologies, Inc. (Tecan Trading AG), Vela Diagnostics, CD Genomics, HTG Polymerase Chain Reaction, Inc., and others.

Polymerase Chain Reaction Market

Polymerase Chain Reaction Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key PCR companies, including Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Qiagen, Agilent Technologies Inc., Standard Biotools, F. Hoffmann-La Roche Ltd., Eppendorf, Avance Biosciences Inc., Merck & Co. Inc., Abbott, Promega Corporation, Takara Bio Inc., Endress+Hauser Group Services AG, BioMérieux, GenMark Diagnostics Inc., Grifols SA, Hologic Inc., BD, Sysmex Corporation, Stilla, and others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.